IP Library Granted Patent US 9,173,752
Granted Patent B2
US 9,173,752 · App. 13/476,336 · Granted Nov 3, 2015

Coil bioabsorbable bifurcation stent

Inventor: Shih-Horng Su (Irvine, CA)
Assignee: Manli International Ltd.
A61F2/88A61F2/89A61F2002/065A61F2002/825A61F2220/0041A61F2230/001
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,173,752
App. No.
13/476,336
Granted
Nov 3, 2015
Kind
B2
Abstract

A bioabsorbable, expandable coil bifurcation stent having a first, second, and third segment, in which the second and third segments are extensions of a coiled fiber in the first segment. Also disclosed is a three-segment expandable coil bifurcation stent in which the second and third segments extend from supporting fibers in the first segment. Further disclosed is an expandable bifurcation stent in which supporting fibers in the first segment also support the second and third segments. The three segments are independently adjustable to fit varied geometries.

Claims (7)

1. A bioabsorbable stent convertible between a furled state and an expanded state, comprising;

a first segment having a longitudinal axis and a circumference, the first segment containing a helically coiled fiber extending along the entire longitudinal axis of the first segment and extending around the circumference of the first segment and defining a first coil structure, and a first longitudinally disposed supporting fiber and a second longitudinally disposed supporting fiber each spaced around the first coil structure and attached at selected points along the length of the first coil structure;

a second segment having a longitudinal axis and a circumference, the second segment containing a second helically coiled fiber extending along the entire longitudinal axis of the second segment and extending around the circumference of the second segment and defining a second coil structure, and a portion of the first longitudinally disposed supporting fiber attached at selected points along the length of the second coil structure; and

a third segment having a longitudinal axis and a circumference, the third segment containing a third helically coiled fiber extending along the entire longitudinal axis of the third segment and extending around the circumference of the third segment and defining a third coil structure, and a portion of the second longitudinally disposed supporting fiber attached at selected points along the length of the third coil structure, wherein all of the helically coiled fibers and supporting fibers contain bioabsorbable polymeric material.

2. The bioabsorbable stent of claim 1 , wherein each of the helically coiled fibers or each of the supporting fibers includes a drug.

3. The bioabsorbable stent of claim 1 , wherein the bioabsorbable stent has a predetermined rate of degradation.

4. The bioabsorbable stent of claim 1 , wherein the bioabsorbable polymeric material is selected from the group consisting of polydioxanone, polyglycolide, polycaprolactone, polylactides, poly-L-lactide, poly-D,L-lactide, poly (L-lactide-co-glycolide), poly (D,L-lactide-co-glycolide), poly (L-lactide-co-D,L-lactide), poly (L-lactide-co-trimethylene carbonate), polyhydroxyvalerate, and ethylvinylacetate.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2013
From: DUNING INCORPORATED
To: MANLI INTERNATIONAL LTD.
Reel/Frame 029614/0679 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2012
From: SU, SHIH-HORNG
To: DUNING INCORPORATED
Reel/Frame 028240/0993 →
Continuity (1)
Related Publication 20130310920A1 · Nov 21, 2013